游泳至幸福:预防老年人的脆弱性
Halina Kusz1, Ali Ahmad2,3, Jeffrey Borgeson1
1McLaren Flint Graduate Medical Education, Department of Medicine, College of Human Medicine, Michigan State University, East Lansing, MI, USA (HK, JB).
American journal of lifestyle medicine
|November 10, 2025
概括
定期游泳可以预防老年人的虚弱,改善情绪和生活质量. 这种生活方式干预,结合患者与医生的合作,为脆弱性管理提供了一种成功的方法.
科学领域:
- 老年医学 老年医学
- 生活方式干预措施 生活方式干预
- 公共卫生 公共卫生
背景情况:
- 虚弱是一种严重的老年综合征,影响老年人的生活质量.
- 生活方式干预在预防,治疗和扭转脆弱方面显示出有前途.
- 身体活动至关重要,但老年美国人中仍然普遍存在不活动.
研究的目的:
- 介绍一个关于成功预防脆弱性的案例研究.
- 突出定期体育活动的作用,特别是游泳,在管理脆弱性.
- 强调协作护理在老年综合征管理中的重要性.
主要方法:
- 采用了一个案例研究方法.
- 干预的重点是定期游泳作为主要的生活方式修改.
- 患者,家人和医生之间的合作是该方法的组成部分.
主要成果:
- 该案例表明,通过定期游泳,预防脆弱性有了显著的改善.
- 观察到患者情绪和整体生活质量得到改善.
- 药物使用的优化是一个值得注意的结果.
结论:
- 定期游泳是一种有效的生活方式干预措施,用于预防老年人的脆弱性.
- 多学科的协作有助于成功管理脆弱性.
- 生活方式干预可以全面改善老年人的健康和福祉.
相关概念视频
Drug Dosing: Geriatric Patients
215
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
215
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
221
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
221
Pharmacodynamics in Geriatric Patients: Effects of Age
180
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
180
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
226
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
226
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
213
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
213
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
188
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
188


